Tag: antimicrobial resistance
Feedlot sampling uncovers neglected gene involved in antimicrobial resistance
Researchers at the University of Saskatchewan have discovered how a previously overlooked gene is involved in antimicrobial resistance. The antimicrobial resistance gene (ARG) encodes for an α/β-hydrolase, named EstT, capable of inactivating macrolide antibiotics commonly used to treat livestock diseases. The findings are published in Proceedings of the National Academy of Sciences (PNAS). The research […]
Exploring the relationships between antimicrobial use and resistance in Canadian turkey flocks
In a study published in Frontiers in Microbiology, researchers have modelled how antimicrobial use impacts the emergence of antimicrobial resistance (AMR) in Escherichia coli isolated from Canadian turkey flocks. The findings will help inform antimicrobial stewardship in the turkey sector. Csaba Varga, assistant professor of epidemiology at University of Illinois Urbana-Champaign, and his research group […]
PIG-PARADIGM project aims to reduce the need for antibiotics
Researchers from universities in Denmark, the United States and the Netherlands are collaborating on a project to improve intestinal resilience in developing piglets, with the aim of advancing knowledge on how to prevent bacterial infections and reducing the need for antimicrobials. The 5-year project, called Preventing Infection in the Gut of developing Piglets – and […]
Antimicrobial Resistance – Genomes, Big Data and Emerging Technologies (Virtual Conference)
Third Wellcome Connecting Science meeting on Antimicrobial Resistance (AMR). This year’s programme will include antimicrobial discovery and global trends in AMR, in addition to the focus on genomic evidence and the other tools for surveillance. It will highlight the recent advances in the rapidly emerging field of machine learning and GWAS methods to predict AMR. […]
6th AMR Conference 2022, Basel, Switzerland
The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.